Company Filing History:
Years Active: 2021
Title: Pei-Ying Liao: Innovator in Neurodegenerative Disorder Treatments
Introduction
Pei-Ying Liao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. His innovative approach has led to the development of a unique oral dosage formulation that addresses critical challenges in medication delivery.
Latest Patents
Pei-Ying Liao holds a patent for an "Oral pH independent dosage formulation for treating neurodegenerative disorders." This formulation is designed to be effective across a wide pH range, from about 1.0 to about 7.0. It combines both sustained-release and immediate-release drugs, specifically memantine and donepezil, to enhance therapeutic outcomes for patients suffering from neurodegenerative conditions.
Career Highlights
Liao is associated with Center Laboratories, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective treatment options that improve the quality of life for individuals with neurodegenerative disorders. His dedication to innovation in this field is evident through his patent and ongoing research initiatives.
Collaborations
Pei-Ying Liao collaborates with talented colleagues, including Meng-Ju Lee and Shu-Hsien Chang. Their combined expertise fosters a productive environment for developing groundbreaking solutions in the pharmaceutical industry.
Conclusion
Pei-Ying Liao's contributions to the treatment of neurodegenerative disorders through innovative oral dosage formulations highlight his role as a leading inventor in the pharmaceutical field. His work not only showcases his inventive spirit but also promises to make a significant impact on patient care.